Sign in
4/A

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-007111

Options or other derivatives

  • Director acquired 39,475 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gumulka Jerzy · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-21 Grant or award : show line 1 in the form Option to purchase common stock +39,475 45,428 D
Loading xslF345X05/ownership.xml…